Jul 27, 2025
TEN RESEARCHERS HONORED AT ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
Jul 27, 2025
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: FRED AND BARBARA ERB FAMILY FOUNDATION HONORED FOR PHILANTHROPIC LEADERSHIP IN ALZHEIMER'S RESEARCH
Jul 25, 2025
U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE
Jun 12, 2025
New Analysis Finds Dementia Caregivers More Likely to Report Modifiable Risk Factors That Increase Their Own Risk for Dementia
May 16, 2025
Alzheimer's Association Statement on First Blood Test Used in Diagnosing Alzheimer's Disease Cleared for Use by FDA
Dec 23, 2024
NEW CLINICAL PRACTICE GUIDELINE ON THE PROCESS FOR DIAGNOSING ALZHEIMER'S DISEASE OR A RELATED FORM OF COGNITIVE IMPAIRMENT OR DEMENTIA
Dec 02, 2024
Samuel L. Jackson, Kimberly Williams-Paisley and Diedrich Bader Join Alzheimer's Association's First-Ever Fundraising Advertising Campaign "Generation Hope"
Nov 01, 2024
Alzheimer's Association Encourages Dementia Caregivers to Make Their Health and Well-Being an Equal Priority
Oct 08, 2024
Alzheimer's Association to Celebrate 40th Anniversary of the Imagine Benefit, Built on the Legacy of the Rita Hayworth Gala
Sep 04, 2024
Alzheimer's Association Collaborates with Hallmark Media and Ashley Williams for First-Ever Walk to End Alzheimer's Appearance in a Feature Film
Aug 22, 2024
Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access
Aug 01, 2024
RESEARCH ADVANCES AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
Jul 31, 2024
PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS MAY LOWER RISK
Jul 30, 2024
GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA
Jul 29, 2024
EXPOSURE TO WILDFIRE SMOKE GREATLY RAISES RISK OF DEMENTIA DIAGNOSIS
Jul 28, 2024
ALZHEIMER'S DISEASE BLOOD TESTS COULD IMPROVE DIAGNOSIS IN PRIMARY CARE, SPEED RECRUITING FOR RESEARCH & REDUCE WAIT TIMES
Jul 26, 2024
Alzheimer's Association Statement on European Medicines Agency Negative Opinion on Leqembi for the Treatment of Alzheimer's Disease
Jul 02, 2024
Alzheimer's Association Welcomes U.S. FDA Approval of Kisunla (donanemab)
Jun 10, 2024
ALZHEIMER'S ASSOCIATION WELCOMES FDA ADVISORY COMMITTEE UNANIMOUS VOTE OF EFFICACY OF DONANEMAB FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE
Jun 03, 2024
Alzheimer's Association Encourages Americans to Take Charge of Their Brain Health